SFX by Ex Libris Inc.

Title:	Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?
Source:	Chemistry & biology [1074-5521] Oefner, C yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chen, A. "Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines." Bioorganic and medicinal chemistry letters 21.13 (2011): 3970-5.
description	2.	Güller, R. "Piperidine-renin inhibitors compounds with improved physicochemical properties." Bioorganic & medicinal chemistry letters 9.10 (1999): 1403-8.
description	3.	Domling, A. "Parallel synthesis of arrays of 1,4,5-trisubstituted 1-(4-piperidyl)-imidazoles by IMCR: a novel class of aspartyl protease inhibitors." Arkivoc 12 (2007): 99-109.
description	4.	Boss, C. "Inhibitors of the Plasmodium Falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents." Current medicinal chemistry 10.11 (2003): 883-907.
description	5.	Vieira, E. "Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site." Bioorganic & medicinal chemistry letters 9.10 (1999): 1397-1402.
description	6.	Hof, F. "Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV." Angewandte Chemie (International ed.) 45.13 (2006): 2138-2141.
description	7.	Marques, Francine Z. "Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs." Hypertension 58.6 (2011): 1093-1098.
description	8.	Bentley, Philip A. "Recurrent vestibular paroxysms associated with systemic hypertension in a dog." Journal of the American Veterinary Medical Association 239.5 (2011): 652-655.
description	9.	Tran, T. "Design and optimization of potent gp120-CD4 inhibitors." Bioorganic & medicinal chemistry letters 19.17 (2009): 5250-1527.
description	10.	Xu, Z. "Optimization of orally bioavailable alkyl amine renin inhibitors." Bioorganic & medicinal chemistry letters 20.2 (2010): 694-699.
description	11.	Taniguchi, T. "A Diastereocontrolled Synthesis of (+)-Febrifugine: A Potent Antimalarial Piperidine Alkaloid." Organic letters 2.20 (2000): 3193-3195.
description	12.	Kratochwil, N.A. A. "Predicting plasma protein binding of drugs: a new approach." Biochemical Pharmacology 64.9 (2002): 1355-1374.
description	13.	Bursavich, Matthew G. "From peptides to non-peptide peptidomimetics: Design and synthesis of new piperidine inhibitors of aspartic peptidases." Organic letters 3.15 (2001): 2317-2320.
description	14.	Carcache, David A. "Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 7-azabicyclo[2.2.1]heptane scaffold." Helvetica chimica acta 86.6 (2003): 2173-2191.
description	15.	Gelb, Michael H. "Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics." Molecular and biochemical parasitology 126.2 (2003): 155-63.
description	16.	Boss, C. "Endothelin receptor antagonists: Structures, synthesis, selectivity and therapeutic applications." Current medicinal chemistry 9.3 (2002): 349-383.
description	17.	Frissen, A. E. "Synthesis of 1,3-dihydrofuro[3,4-c]pyridines and 5,7-dihydrofuro[3,4-b]pyridines by intramolecular Diels-Alder reactions of pyrimidines. Investigation of the effect of steric interactions on the reaction rate." Tetrahedron 45.17 (1989): 5611-5620.
description	18.	Carcache, David A. "A new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene scaffold." Helvetica chimica acta 86.6 (2003): 2192-2209.
description	19.	Tice, Colin M. "Design and optimization of renin inhibitors: Orally bioavailable alkyl amines." Bioorganic & medicinal chemistry letters 19.13 (2009): 3541-3545.
description	20.	Brown, S. "Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats." Journal of veterinary internal medicine 21.3 (2007): 542-58.